The wet patient: understanding patients with overactive bladder and incontinence

References

• Abrams P, Cardozo L, Fall M, et al. The standardization of terminology in lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002;187:116–26
   PubMed Web of Science ®Google Scholar
• Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. Br J Urol Int 2001;87:760–6
   Google Scholar
• Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327–36
   PubMed Web of Science ®Google Scholar
• Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology 2002;60(Suppl 5A):7–12
   Google Scholar
• Payne CK. Epidemiology, pathophysiology, and evaluation of urinary incontinence and overactive bladder. Urology 1998;51(Suppl 2A):3–10
   Google Scholar
• Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. Br Med J 1980;281:1243–5
   PubMed Web of Science ®Google Scholar
• Diokno AC, Brock BM, Brown MB, Herzog AR. Prevalence of urinary and other urological symptoms in the non-institutionalized elderly. J Urol 1986;136:1022–5
   PubMed Web of Science ®Google Scholar
• Ouslander JG, Kane RL, Abrass IB. Urinary incontinence in elderly nursing home patients. J Am Med Assoc 1982;248:1194–8
   Google Scholar
• van der Vaart CH, de Leeuw JRJ, Roovers JPWR, Heintz APM. The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women. Br J Urol Int 2002;90:544–9
   Google Scholar
• Mitteness LS. Knowledge and beliefs about urinary incontinence in adulthood and old age. J Am Geriatr Soc 1990;38:374–8
   PubMed Web of Science ®Google Scholar
• Keller SL. Urinary incontinence: occurrence, knowledge, and attitudes among women aged 55 and older in a rural Midwestern setting. J Wound Ostomy Continence Nurs 1999;26:30–8
   PubMedGoogle Scholar
• Liberman JN, Hunt TL, Stewart WF, et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology 2001;57:1044–50
   PubMed Web of Science ®Google Scholar
• Brown JS, Grady D, Ouslander J, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstet Gynecol 1999;94:66–70
   PubMed Web of Science ®Google Scholar
• Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. Br J Obstet Gynaecol 2003;110:247–54
   Google Scholar
• Fantl J, Newman D, Colling J, et al. Urinary incontinence in adults: acute and chronic management. Clinical practice guideline No. 2, 1996 update. Rockville, MD: US Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96–0682. March 1996
   Google Scholar
• Klingele CJ, Carley ME, Hill RFC. Patient characteristics that are associated with urodynamically diagnosed detrusor instability and genuine stress incontinence. Am J Obstet Gynecol 2002;186:866–8
   Google Scholar
• Jeffcoate TNA, Francis WJA. Urgency incontinence in the female. Am J Obstet Gynecol 1996;94:604–18
   Google Scholar
• Brown JS, McGhan WF, Chokroverty S. Comorbidities associated with overactive bladder. Am J Manag Care 2000;6:S574–9
   PubMed Web of Science ®Google Scholar
• Brown JS, Vittinghoff E, Wyman JF, et al. Urinary incontinence: does it increase risk for falls and fractures? J Am Geriatr Soc 2000;48:721–5
   PubMed Web of Science ®Google Scholar
• Thom DH, Haan MN, Van Den Eeden SK. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing 1997;26:367–74
   Google Scholar
• Johnson TM 2nd, Bernard SL, Kincade JE, Defriese GH. Urinary incontinence and risk of death among community-living elderly people: results from the National Survey on Self-Care and Aging. J Aging Health 2000;12: 25–46
   Google Scholar
• Chiaffarino F, Parazzini F, Lavezzari M, Giambanco V. Impact of urinary incontinence and overactive bladder on quality of life. Eur Urol 2003;43:535–8
   PubMed Web of Science ®Google Scholar
• Ricci JA, Baggish JS, Hunt TL, et al. Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder. Clin Ther 2001;23:1245–59
   PubMed Web of Science ®Google Scholar
• Diokno A. Epidemiology and psychosocial aspects of incontinence. Urol Clin North Am 1995;22:481–5
   PubMed Web of Science ®Google Scholar
• Dugan E, Cohen SJ, Bland DR, et al. The association of depressive symptoms and urinary incontinence among older adults. J Am Geriatr Soc 2000;48:413–6
   PubMed Web of Science ®Google Scholar
• Zorn BH, Montgomery H, Pieper K, et al. Urinary incontinence and depression. J Urol 1999;162:82–4
   PubMed Web of Science ®Google Scholar
• Shaw C, Tansey R, Jackson C, Hyde C, Allan R. Barriers to help seeking in people with urinary symptoms. Fam Pract 2001;18:48–52
   Google Scholar
• Diokno A, Lee P, Zorn BH, et al. Factors associated with clinical assessment of overactive bladder and selection of treatment. Clin Ther 2001;23:1542–51
   PubMed Web of Science ®Google Scholar
• Boone TB, Kusek JW, Nyberg LM, et al. Treatment patterns and associated symptom improvement during six months of care for overactive bladder: a prospective, observational study. Clin Ther 2002;24:397–408
   PubMed Web of Science ®Google Scholar
• Garnett S, Abrams P. The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder. J Urol 2003;169:843–8
   Google Scholar
• Kelleher CJ, Kreder KJ, Pleil AM, Burgess SM, Reese PR. Long-term health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 2002;8:S616–30
   Google Scholar
• Hu TW, Wagner TH. Economic considerations in overactive bladder. Am J Manag Care 2000;6:S591–8
   PubMed Web of Science ®Google Scholar
• Kelleher CJ. Economic and social impact of OAB. Eur Urol Suppl 2002;1:11–6
   Web of Science ®Google Scholar
• Hu TW, Wagner TH, Bentkover JD, et al. Estimated economic costs of overactive bladder in the United States. Urology 2003;61:1123–8
   PubMed Web of Science ®Google Scholar
• Wilson L, Brown JS, Shin GP, Luc KO, Subak LL. Annual direct cost of urinary incontinence. Obstet Gynecol 2001;98:398–406
   Google Scholar
• Wagner TH, Hu TW, Bentkover J, et al. Health-related consequences of overactive bladder. Am J Manag Care 2002;8:S598–607
   PubMed Web of Science ®Google Scholar
• McClish DK, Wyman JF, Sale PG, Camp J, Earle B. Use and costs of incontinence pads in female study volunteers. Continence Program for Women Research Group. J Wound Ostomy Continence Nurs 1999;26:207–8, 210–3
   Google Scholar
• Dmochowski R. Interventions for detrusor activity: the case for multimodal therapy. Rev Urol 2002;4(Suppl 4):S19–27
   PubMedGoogle Scholar
• Wallace SA, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults (Cochrane Review). In: The Cochrane Library, issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd
   Google Scholar
• Burgio KL, Goode PS, Locher JL, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. J Am Med Assoc 2002;288:2293–9
   PubMed Web of Science ®Google Scholar
• Subak LL, Quesenberrry CP, Posner SF, Cattolica E, Soghi Kian K. The effect of behavioral therapy on urinary incontinence: a randomized controlled trial. Obstet Gynecol 2002;100:72–8
   Google Scholar
• Goode PS, Burgio KL, Locher JL, et al. Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women. J Am Med Assoc 2003;290:345–52
   PubMed Web of Science ®Google Scholar
• Burgio KL, Locher JL, Goode PS, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. J Am Med Assoc 1998;280: 1995–2000
   PubMed Web of Science ®Google Scholar
• Berghmans LC, Hendriks HJ, De Bie RA, van Waalwijk van Doorn ES, Bo K, van Kerrebroeck PE. Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol Int 2000;85:254–63
   Google Scholar
• Mattiasson A, Blaakaer J, Hoye K, Wein AJ. Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. Br J Urol Int 2003;91:54–60
   Google Scholar
• Thakar R, Stanton S. Regular review: management of urinary incontinence in women. Br Med J 2000;321:1326–31
   PubMed Web of Science ®Google Scholar
• Robinson D, Khullar V, Cardozo L. Pharmacological management of detrusor instability. Int Urogynecol J 2001;12:271–8
   PubMedGoogle Scholar
• Yoshimura N, Chancellor MB. Current and future pharmacological treatment for overactive bladder. J Urol 2002;168:1897–913
   PubMed Web of Science ®Google Scholar
• Ouslander JG. Management of overactive bladder. New Engl J Med 2004;350:786–99
   PubMed Web of Science ®Google Scholar
• Serels S, Stein M. Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women. Neurourol Urodyn 1998;17(1):31–6
   PubMed Web of Science ®Google Scholar
• Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women (Cochrane Review) In: The Cochrane Library, issue 2, 2003. Oxford, UK: Update Software
   Google Scholar
• Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003;62(Suppl 4A):45–51
   Google Scholar
• Andersson KE. Antimuscarinics for treatment of overactive bladder. Lancet Neurol 2004;3:46–53
   PubMed Web of Science ®Google Scholar
• Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. Br Med J 2003;326:841–4
   PubMed Web of Science ®Google Scholar
• Drutz HP, Appell RA, Gleason D, Klimberg I, Radomski S. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int Urogynecol J 1999;10:283–9
   Google Scholar
• Nilvebrant L. The mechanism of action of tolterodine. Rev Contemp Pharmacother 2000;11:13–27
   Web of Science ®Google Scholar
• Nilvebrant L, Andersson KE, Gillberg PG, Stahl M, Sparf B. Tolterodine – a new bladder-selective antimuscarinic agent. Eur J Pharmacol 1997;327:195–207
   Google Scholar
• Appell RA, Sand P, Dmochowski R, et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clin Proc 2001;76:358–63
   PubMed Web of Science ®Google Scholar
• van Kerrebroeck P, Kreder K, Jonas U, Zinner N, Wein A. Tolterodine study group. Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology 2001;57:414–21
   Google Scholar
• Gupta SK, Sathyan G. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin. J Clin Pharmacol 1999;39:289–96
   PubMed Web of Science ®Google Scholar
• Dmochowski RR, Appell RA. Advancements in pharmacologic management of the overactive bladder. Urology 2000;56(Suppl 6A):41–9
   Google Scholar
• Dmochowski RR. The effect of pH on drug release from extended-release formulations of oxybutynin and tolterodine. 2nd International Consultation on Incontinence of the World Health Organization. Paris, July 2001
   Google Scholar
• Diokno A, Sand P, Peters K, Kell S. A prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine. Mayo Clin Proc 2003;78:687–95
   PubMed Web of Science ®Google Scholar
• Ortho-McNeil Pharmaceutical, data on file
   Google Scholar
• Physicians’ desk reference. 56th ed. Montvale, NJ: Medical Economics Co, 2002. p. 2803
   Google Scholar
• Hooper P, Tincello DG, Richmond DH. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study. Br J Urol 1997;80:414–6
   Google Scholar
• Bang LM, Easthope SE, Perry CM. Transdermal oxybutynin for overactive bladder. Drugs Aging 2003;20:857–64
   PubMedGoogle Scholar
• Davila GW, Daugherty CA, Sander SW, for the Transdermal Oxybutynin Study Group. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate-release oral oxybutynin treatment of patients with urge urinary incontinence. J Urol 2001;166:140–5
   Google Scholar
• Dmochowski RR, Sand PK, Zinner NR, Gittelman MC, Davila GW, Sanders SW, for the Transdermal Oxybutynin Study Group. Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 2003;62: 237–42
   Google Scholar
• Diokno A, Sand P, Labasky R, et al. Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol 2002;34:43–9
   PubMedGoogle Scholar
• Loch A, Loch T, Osterhage J, Alloussi S, Stöckle M. Botulinum-A toxin detrusor injections in the treatment of non-neurologic and neurologic cases of urge incontinence [abstract]. Eur Urol Suppl 2003;2:172
   Google Scholar
• Radziszewski P, Borkowski A. Botulinum toxin type A intravesical injections for instable bladder overactivity [abstract]. Eur Urol Suppl 2002;1:134
   Google Scholar
• Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 2003;44:165–74
   Google Scholar
• Van Kerrebroeck PEV. Neuromuscular and other electro-stimulatory techniques. Scand J Urol Nephrol Suppl 2002;210:82–6
   PubMedGoogle Scholar
• Milsom I, Stewart W, Thuroff J. The prevalence of overactive bladder. Am J Manag Care 2000;6:S565–73
   PubMed Web of Science ®Google Scholar